USPTO Rules on Patent Term Adjustment Set to Change Following CAFC Decision

February 5, 2019

The USPTO may be forced to rethink its regulations on calculating PTA following the Court of Appeals for the Federal Circuit precedential decision in Supernus Pharmaceuticals v Iancu, write Sharon Roberg-Perez, Jake Holdreith and Jeff Hovden of Robins Kaplan LLP.

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.

Disclaimer

Sharon E. Roberg-Perez, Ph.D.

Partner

Co-Chair, Diversity Committee

Jake M. Holdreith

Partner

Member of the Executive Board

Back to Top